HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].

Abstract
Paraneoplastic neurologic syndromes are disorders of the nervous system function caused by cancer but not due to metastatic disease, vascular or metabolic deficits, infections, nutritive deficiency, nor side effects of antineoplastic drugs or irradiation. Immunologic factors probably play the crucial role in the pathogenesis of paraneoplastic neurologic syndromes, but nonimmunologic mechanisms that include metabolic abnormalities and competition for substrate are also involved. Paraneoplastic cerebellar degeneration most commonly occurs in the setting of gynecologic cancers, but it accompanies the small-cell lung cancer too. Other tumors are infrequently associated with cerebellar degeneration. Several paraneoplastic antibodies have been identified in patients with paraneoplastic cerebellar degeneration. Their association with particular cancers may help identify an occult lesion. Anti-Yo antibodies are directed against Purkinje cell antigens and occur in patients with cerebellar degeneration who have breast cancer or gynecologic tumors. A target antigen of anti-Yo antibody is CDR2 protein that is normally expressed only in the brain and testis. Patients with paraneoplastic cerebellar degeneration present with dizziness, nausea and vomiting followed by gait instability, diplopia, gait and appendicular ataxia, dysarthria and dysphagia. Therapeutic options include tumor excision, chemotherapy and/or irradiation, and adjuvant therapy with glucocorticoids, immunoglobulins and plasmapheresis. The role of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration is still uncertain. Reports of its efficacy are anecdotal. We present patient with paraneoplastic cerebellar degeneration with positive anti-Yo antibodies and tumor of the ovaries whose neurologic status significantly improved after four daily plasmaphereses, which was accompanied by a fourfold decrease in the anti-Yo antibodies titer. Further investigations are needed to define a protocol for plasmapheresis in the treatment of patients with paraneoplastic syndromes.
AuthorsNikolina Basić-Jukić, Petar Kes, Vanja Basić-Kes, Bruna Brunetta
JournalActa medica Croatica : casopis Hravatske akademije medicinskih znanosti (Acta Med Croatica) Vol. 58 Issue 1 Pg. 63-6 ( 2004) ISSN: 1330-0164 [Print] Croatia
Vernacular TitleZnacenje plazmafereze u lijecenju paraneoplasticne cerebelarne degeneracije.
PMID15125396 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Autoantibodies
  • CDR2 protein, human
  • DNA-Binding Proteins
  • Neoplasm Proteins
  • Nerve Tissue Proteins
Topics
  • Autoantibodies (blood)
  • DNA-Binding Proteins (immunology)
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Proteins (immunology)
  • Nerve Tissue Proteins
  • Ovarian Neoplasms (complications)
  • Paraneoplastic Cerebellar Degeneration (diagnosis, immunology, therapy)
  • Plasmapheresis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: